The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis

This publication has 58 references indexed in Scilit:

• Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis
  Rheumatology International, 2013
• Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
  Clinical Rheumatology, 2012
• Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients
  Arthritis & Rheumatism, 2011
• Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan
  The Journal of Rheumatology, 2011
• Rituximab treatment of the anti-synthetase syndrome—a retrospective case series
  Rheumatology, 2009
• Interstitial lung disease associated with amyopathic dermatomyositis: Review of 18 cases
  Respiratory Medicine, 2007
• Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study
  Clinical Rheumatology, 2007
• Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
  Rheumatology, 2006
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Quantifying heterogeneity in a meta‐analysis
  Statistics in Medicine, 2002